{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9NZQ7",
      "entity_text" : "PD-L1",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-0568" ],
      "Organ" : [ "uberon:UBERON:0000170" ],
      "CellType" : [ "cl:CL:0000738" ]
    }
  },
  "verbose_text" : "In analogy to the 111 In-atezolizumab study that was described above XREF_BIBR, imaging of no, low, intermediate or high PD-L1-expressing tumors was performed, showing comparable results, i.e., uptake correlating to levels of PD-L1 expression in these tissues XREF_BIBR.",
  "reading_complete" : "2020-08-02T09:41:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T09:39:06Z",
  "trigger" : "expression",
  "evidence" : [ "PD-L1 expression" ],
  "pmc_id" : "6037030",
  "score" : 0
}